Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Peter Hillmen
Trial Re-Investment to Build Better Research for Better Impact
The Lancet
Medicine
Genomic Disruption of the Histone Methyltransferase SETD2 in Chronic Lymphocytic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Long-Term Follow-Up of the RESONATE™ Phase 3 Trial of Ibrutinib Versus Ofatumumab
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Significant Hemolysis Is Not Required for Thrombosis in Paroxysmal Nocturnal Hemoglobinuria
Haematologica
Hematology
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria
American Journal of Hematology
Hematology
DAPK3 Participates in the mRNA Processing of Immediate Early Genes in Chronic Lymphocytic Leukaemia
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Highly Selective SYK Inhibitor, GSK143, Abrogates Survival Signals in Chronic Lymphocytic Leukaemia
British Journal of Haematology
Hematology
Safety and Efficacy of Ibrutinib in Patients With Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) Who Have Undergone Prior Allogeneic Stem Cell Transplant
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
